Trulicity is a prescription drug approved by the Food and Drug Administration (FDA) to treat type 2 diabetes in adults. Trulicity is considered an adjunct treatment to diet and exercise. Trulicity is also referred to by its drug name, Dulaglutide.
Trulicity is an incretin mimetic. Trulicity is also a glucagon-like peptide-1 (GLP-1) receptor agonist. Trulicity mimes the effects of incretin, which signals the pancreas to make more insulin and prevents the liver from releasing glucose. Trulicity is believed to work by normalizing blood glucose levels.
How do I take it?
Prescribing information states that Trulicity should be administered via a subcutaneous injection once a week.
Trulicity comes as a prefilled pen or prefilled syringe.
The FDA-approved label for Trulicity lists common side effects including nausea, diarrhea, abdominal pain, loss of appetite, and vomiting.
Rare but serious side effects listed for Trulicity include thyroid cancer, pancreatitis, kidney problems, and severe gastrointestinal reactions.